A $7.4 billion settlement agreement with the founders of Purdue Pharma is almost sealed in ink — and Utah will get $57 million from the deal.

BioMarin Pharmaceutical Inc. has a 1-year low of $52.93 and a 1-year high of $94.85. The firm has a market capitalization of $10.78 billion, a P/E ratio of 25.55, a price-to-earnings-growth ratio ...

This study describes a synthetic route to access LY104, a structurally novel compound investigated for the treatment of chronic obstructive pulmonary disease (COPD). Our approach to LY104 encompasses ...

Select buzzing stocks including Tata Motors Ltd, Blue Star Ltd and Stride Pharma Science Ltd are likely to remain under the spotlight of traders for the session today. Here is what Rajesh Palviya ...

Blue Cross Blue Shield of Michigan was hit with a proposed class action claiming it funnels its self-funded health plan clients through a convoluted cost-savings program that’s actually an engine ...

A mass fish die-off in Iraq’s marshlands is the latest hit to a region troubled by drought and water scarcity. Ongoing drought is expected to drop China’s national wheat harvest to its lowest output ...

Moderate House Republicans from high-tax blue states are warning senators that they will not give the “big, beautiful bill” a final stamp of approval if the Senate changes their proposal for ...

As Republicans work to advance their megabill, the debate over the $10,000 cap on the federal deduction for state and local taxes (SALT) is again heating up.

Originally working in pharmaceutical chemistry, she is now an integral member of a team of scientists studying blue carbon – the carbon captured by the ocean and coastal ecosystems, in a natural ...

President Trump’s domestic agenda bill is spurring a debate over whether blue states are subsidizing red states. After a successful pressure campaign from blue-state Republicans, the House ...